GDC-0032 Size:Solid 2 mg It has Gram-negative coverage which

It has Gram-negative coverage which includes Pseudomonas aeruginosa but limited Gram-positive coverage

InChi: InChI=1S/C18H24N2O3S

61)/b54-53+/t33-

Smiles: CC(C)(C)C1C=CC(=CC=1)C(=O)NC(=S)NC1C=CC(N)=CC=1

InChi: InChI=1S/C17H26O4/c1-2-3-4-5-6-7-8-9-10-11-13-16(20)14(18)12-15(19)17(13)21/h12

GDC-0032 Size:Solid 2 mg It has Gram-negative coverage whichTaselisib, also known as GDC0032 or RG7606, is a selective, potent, orally bioavailable inhibitor of PI3Ka with a Ki = 0. 2nM, and with reduced inhibitory activity against PI3K. This selectivity profile, and excellent pharmacokinetic and pharmaceutical properties, allowed for greater efficacy in vivo at the maximum tolerated dose relative to a pan Class I PI3K inhibitor in PIK3CA mutant xenografts. Notably, GDC 0032 preferentially inhibited PIK3CA